| Literature DB >> 29960829 |
Carolina Garcia-Vidal1, Ana Alastruey-Izquierdo2, Manuela Aguilar-Guisado3, Jordi Carratalà4, Carmen Castro5, Mario Fernández-Ruiz6, José María Aguado6, José María Fernández7, Jesús Fortún8, José Garnacho-Montero9, Joan Gavaldà10, Carlota Gudiol4, Jesús Guinea11, Alicia Gómez-López2, Patricia Muñoz11, Javier Pemán12, Montserrat Rovira13, Isabel Ruiz-Camps10, Manuel Cuenca-Estrella2.
Abstract
Aspergillus infection is a significant cause of morbi-mortality in an at-risk population. The Study Group of Fungal Infections (GEMICOMED) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) has reviewed announcements made in invasive aspergillosis management. We have organized our recommendations in such a way as to provide a guide in resolving different clinical situations concerning the entire spectrum of invasive diseases caused by Aspergillus in various populations. Diagnostic approach, treatment and preventions strategies are outlined. It is not our aim that these guidelines supplant clinical judgment with respect to specific patients; however, it is our objective to perform a comprehensive summary of quality of care evidence for invasive aspergillosis management in different settings.Entities:
Keywords: Aspergillosis; Aspergilosis; Isavuconazol; Isavuconazole; Manejo clínico; Monitorización de noveles; Therapeutic drug monitoring; Tratamiento; Treatment; Voriconazol; Voriconazole
Mesh：
Year: 2018 PMID： 29960829 DOI： 10.1016/j.eimc.2018.03.018
Source DB: PubMed Journal: Enferm Infecc Microbiol Clin (Engl Ed) ISSN： 2529-993X